Evicenter
MarkdownMedical informationP&T meetings
Ifezuntirgene inilparvovec (AMT-130)

Huntington's disease

Manufacturer
uniQure
Launch
Not announced
Last updated
291 sources

Product information and disease descriptionProduct descriptionProduct information

Co-prescribed/Concomitant therapies

6 evidence topics · 8 sources

Agents, doses, and duration of the immunosuppression regimen

No evidence found.